Your browser doesn't support javascript.
loading
The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapy.
Isaksen, Kathrine T; Galleberg, Renate; Mastroianni, Maria Adele; Rinde, Marit; Rusten, Leiv Sindre; Barzenje, Dlawer; Ramslien, Frode; Fluge, Oystein; Slaaen, Marit; Meyer, Peter; Liestol, Knut; Smeland, Erlend B; Lingjarde, Ole Christian; Holte, Harald; Brodtkorb, Marianne.
Afiliação
  • Isaksen KT; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B cell malignancies, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo.
  • Galleberg R; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen.
  • Mastroianni MA; Department of Hematology, Akershus University Hospital, Lorenskog.
  • Rinde M; Department of Hematology, Vestfold Hospital Trust, Tonsberg.
  • Rusten LS; Department of Surgery, Section of Oncology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen.
  • Barzenje D; Department of Oncology, Ostfold Hospital Trust, Kalnes.
  • Ramslien F; Department of Hematology, Telemark Hospital Trust, Skien.
  • Fluge O; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen.
  • Slaaen M; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; The Research Centre for Age Related Functional Decline and Diseases, Innlandet Hospital Trust, Ottestad.
  • Meyer P; Stavanger University Hospital-Rogaland, Stavanger.
  • Liestol K; Department of Informatics, University of Oslo, Oslo, Norway; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo.
  • Smeland EB; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B cell malignancies, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo.
  • Lingjarde OC; Department of Informatics, University of Oslo, Oslo, Norway; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo.
  • Holte H; KG Jebsen Centre for B cell malignancies, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo.
  • Brodtkorb M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo. meide@ous-hf.no.
Haematologica ; 108(9): 2454-2466, 2023 09 01.
Article em En | MEDLINE | ID: mdl-36861406
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Atividades Cotidianas / Linfoma Difuso de Grandes Células B Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Atividades Cotidianas / Linfoma Difuso de Grandes Células B Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article